Journal of diabetes investigation
Cardiovascular and kidney benefits of GLP-1 receptor agonists across large randomized placebo-controlled trials.
Satoshi Yoshiji, Nobuya Inagaki
Published: 202510.1111/jdi.70166
No abstract available for this study.
Satoshi Yoshiji, Nobuya Inagaki
No abstract available for this study.